⌘K

Home/Filings/4/0001209191-23-033312

4//SEC Filing

Ambrose Kristen 4

Accession 0001209191-23-033312

CIK 0000875320other

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:12 PM ET

Size

4.8 KB

Accession

0001209191-23-033312

Insider Transaction Report

Form 4

Period: 2023-05-30

VERTEX PHARMACEUTICALS INC / MAVRTX

Ambrose Kristen

SVP & Chief Accounting Officer

Transactions

Sale
Common Stock
2023-05-30$329.82/sh−289$95,318→ 6,838 total

Footnotes (1)

[F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001856587

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 4:12 PM ET
Size: 4.8 KB

View on SEC.gov